Morningside Medical Centre Sponsorship

The Morningside Pharmaceuticals team at Leicester County Cricket Clubs's Grace Road ground

For many years both players and visitors to Leicester County Cricket Club’s Grace Road ground had to be treated off-site if they became sick or injured.

Back in 2016 this all changed when Morningside Pharmaceuticals Ltd partnered with LCCC to sponsor the medical centre there.

Today, the Morningside Medical Centre provides treatment facilities during match days, as well as for the local community, and features state-of-the-art match preparation and rehabilitation support from injuries.

The medical centre has a space for a private treatment room, an open plan treatment area and an adjoining trauma room which doubles as a crowd medical facility for use by St John’s Ambulance on match days.

It is also used by the club’s youth Academy as a learning centre about Sports Science and Medicine.

Speaking during the renewal of our partnership in 2018, Leicestershire County Cricket Club’s Chief Executive Wasim Khan MBE, said: “Prior to the creation of the Morningside Medical Centre we had to treat players and visitors off-site. This was not ideal as you have to act quickly if someone becomes seriously ill and requires urgent medical treatment.

“The Morningside Medical Centre is an important part of our new set-up here at the club. We’re delighted to work in partnership with Morningside Pharmaceuticals to be able to offer expert medical support to our players, visitors and the local community.”

Morningside’s Chief Executive, Dr Nik Kotecha OBE, added: “I feel passionately about bringing communities together and making lives healthier.

“We are proud to support LCCC and their work in going into the community and local schools to encourage sport and diversity within sport, which has inspired 20,000 children as part of their extensive schools programme.

“This is an important part of our ethos at Morningside and our sponsorship of the Morningside Medical Centre will ensure that everyone visiting Grace Road will have access to emergency treatment on-site in a modern fully equipped medical facility.”

People & Skills Summit Sponsorship

East Midlands Chamber of Commerce's People & Skills Summit 2021

Morningside Pharmaceuticals are the proud sponsors of the East Midlands Chamber of Commerce’s People and Skills Summit, which took place between 14th June to 18th June 2021.

The week-long series of events provided SMEs, organisations and charities from across East Midlands, with an opportunity to attend webinars from expert speakers and panellists.

During the week our Chairman, Dr Nik Kotecha OBE, took part in a panel Q&A, as part of the session entitled: ‘The Skills Landscape Beyond Recovery’.

The panel explored what skills are required to support recovery and growth, to what extent they exist in the region, and how we can work collectively to deliver skills for the economy beyond the recovery.

During the Q&A the panel looked at the challenges around recruiting talent in the East Midlands, how to plug the so called ‘skills gap’ and whether the Government’s Skills and Education Bill offers the solution.

The panel particularly focused on the need for academia, the public and private sectors to come together to better equip young people with ‘work ready skills’, as well as the need for more exposure to the range of careers available while in education.

A spokesperson from the East Midlands Chamber added: “People and Skills Week brought together businesses alongside academic institutions and thought leaders to identify the practical steps our region can take to address the challenge of accessing people with the right skills.

“With the economy emerging from the impact of the past year, our People and Skills Week explored what skills are required to support recovery and growth, to what extent they exist in the region, and how we can work collectively to deliver skills for the economy beyond the recovery.”

Olympic Champion Rower James Cracknell Supports Award

James Cracknell

Double Olympic Champion Rower James Cracknell has presented a national charity award, which was sponsored by Morningside Pharmaceuticals.

The national Centre for Social Justice Awards’ Small Charity category winner was revealed virtually by James via a video recording to the Oasis Community Centre, in Worksop.

View the Video below to watch James present the award:

 

The CSJ Awards honour the best grassroots, poverty-fighting charities and social enterprises in Britain. All winners received a £10,000 prize, which will go towards providing their often life saving and life changing community work.

The CSJ chose Oasis Community Centre because the charity represents the very best of localism and the power of community spirit. They deal with some of the most complex issues in their area, identifying where need is most acute and being creative enough to come up with the solutions.

The Oasis Community Centre is a beautiful and vibrant 2-acre garden, hidden in the centre of the Kilton estate, Worksop. They operate as the heart of the community through running over 30 projects and activities for all ages, needs and interests. Through their therapeutic interventions, Oasis aim to reduce isolation, to improve health and wellbeing and increase the life opportunities and chances for all people in the area.

The CSJ chose Oasis as the Small Charity category winners because they have developed themselves intentionally to be responsive to the needs of local people and to fully support everyone who comes through their door, with no thresholds or cut-offs.

After winning their award Oasis said they would like to share their model with other community centres around the country, to demonstrate how a small charity with a big dream can make a difference to the world around them.

Congratulations to them from everyone at Morningside Pharmaceuticals.

LCCC Partnership Helps Sports Science Education

Leicestershire County Cricket Club's Morningside Medical Centre

Junior cricketers aged between 10 and 18 will be invited to the Morningside Medical Centre at Leicestershire County Cricket Club to learn about sports science and medicine following the naming rights renewal with Morningside Pharmaceuticals.

The medical centre, in LCCC’s Uptonsteel County Ground, Grace Road, was originally founded in 2016 and back then for the first time enabled players and visitors to be treated onsite for injuries or other medical requirements.

Since then the facility has become a critical treatment area for the players where specialist physio can be carried out, as well as urgent medical assistance provided in an emergency.

As the medical centre has become more established, it has developed into a hub for sports science and medicine, and the junior cricketers from LCCC’s Academy are now being invited to visit and learn more about these key study areas.

Dr Nik Kotecha OBE, Chairman of Morningside Pharmaceuticals, said: “At Morningside we’re immensely proud to continue our support of the Morningside Medical Centre, which is developing into a valuable sports and education hub.

“We’re passionate about promoting sports, healthy living and team work, as well as education, skills and helping young people into the world of work; which is why this initiative resonates so well with our company values.

“Developing sports science is an essential part of the club’s long term plans and in particular we are very supportive of their focus on how sports and physical activity promotes good health, mental health, wellbeing and team work.

“I hope the ongoing programme to invite the young cricketers into the medical centre to learn about sports science and medicine will inspire them to think about a career in these fascinating education disciplines.”

About 225 young cricketers will benefit from the progamme, which is being run through LCCC’s Academy of Cricket, by the Academy Strength and Conditioning Coach; Edd Riley-Gibson, and the Academy Physiotherapist; Ryan Smith.

Sean Jarvis, Chief Executive of LCCC, added: “I would like to thank Morningside Pharmaceuticals for their continued sponsorship of the Morningside Medical Centre, which is a huge part of our ambitions to involve the young people from our Academy in the education and community work taking place at the club.

“Working with the local community, particularly young people, is also very important to us, which is why introducing them to the medical centre’s work is a crucial part of our ambitions to raise awareness of sports science and other sports and medical focused careers.”

Care Packs Provided to Every Colleague

Care Pack for Mental Health Awareness Week

At Morningside Pharmaceuticals, the mental health and wellbeing of our employees is of paramount importance, which is why we were delighted to give a Care Pack to every colleague.

The packs were just a small way to say thank you to all of our hard working and dedicated people, for everything they have achieved throughout the Covid-19 pandemic.

Each pack contained a selection of treats designed to help people relax and unwind, as well as helpful support, advice and information about health and mental health.

The Care Packs were timed to coincide with Mental Health Awareness Week by the Mental Health Foundation, which this year is focussing on nature, and how it is central to our psychological and emotional health.

Morningside is a proud supporter of communities and in particular working with them to ensure everyone has affordable and accessible access to good health and mental health services and support.

Opinion: 5Cs Needed for UK-India Free Trade Agreement

Dr Nik Kotecha OBE

As the UK and India commit to working towards a future free trade agreement, Founder of Morningside Pharmaceuticals Ltd, Dr Nik Kotecha OBE, looks at the 5C’s which are essential to developing relations in the Post-Covid era.    

“Watching the hundreds of funeral pyres light up the night’s sky, as many regions of India struggle to bring the latest wave of Covid-19 under control, has touched the world.

This must have been first and foremost during Prime Minister Boris Johnson’s recent call with India’s PM, Narendra Modi, which also led to an extra £1billion in trade and investment being agreed between the two nations. India has passed 21.5 million cases, and the virus has affected not only the large cities but second cities and rural areas too.

Moving away from the difficulty of the here and now, the UK-India relationship has a bright future. Both Covid and Brexit underscore the importance of the UK’s future economic and trading relationships around the world. Aside from the obvious health effects, the Covid pandemic has depressed the UK economy, which is desperate for growth. Brexit has compounded the challenge as the UK needs to seek fresh relationships with important foreign markets such as India. It was notable that the recent integrated review by the government, which assesses the UK’s future foreign, defence and trading outlook, advocated a pivot to the “Indo Pacific.”

India is an important part of the UK’s post-Brexit future. The country is viewed romantically by many Brits who reference shared language, culture and history, but the current and future relationship can really flourish if we focus on certain areas. The UK-India relationship is meaningful to me for personal and business reasons. Whilst I have lived in the UK for almost 50 years, my family originates from India and I am proud of that. In 1991, I started a pharmaceuticals business called Morningside from a garage and three years later, we started doing business in India. Given my ties to the sub-continent, it was a real privilege when I took part in the business delegation when Prime Minister Theresa May visited India five years ago.

Going forward, the relationship between the UK and India should be characterised by the 5C’s. First, Covid, which both countries have and still suffer from. As we know, the second wave in India has been lethal and there are around 400,000 official cases per day, with the actual number likely to be much higher. The UK has been sending urgent medical supplies to India. It is heartening too that the UK and India have been working together on rolling out vaccines. Over a billion doses of the Oxford-AstraZeneca vaccine are being produced by the Serum Institute of India.

The second C is commerce, which was the focus of last week’s announcement which aims to double trade by 2030. UK-India trade is already worth £23 billion in 2019, and supports around half a million jobs in each other’s economies. Pharma is a particular sector of strength, with UK exports growing by 21.4% to £96.75m in 2019. I know from my visits that India is particularly keen on Britain’s burgeoning expertise in Life Sciences, MedTech and diagnostics.

A Confederation of Indian Industry survey in that same year highlighted the potential of Indian businesses in the UK, identifying 844 Indian companies operating in Britain, with combined revenues of over £48bn. UK political and business leaders appreciate that the Indian economy is expected to have one of the fastest growth rates in the G20 this year, and offers a market of 1.4 billion people. According to many estimates, India will be the third largest economy in the world by 2030. Given these encouraging statistics, therefore, it is no surprise that the UK views India as such an important economic and trade partner.

Third C for community refers to the British Indian community numbering some 1.5 million, which provides the rocket fuel in the relationship. They contribute hugely to the economic, cultural and social fabric of the UK. Whilst comprising just 4% of the UK population, they pay some 10% of taxes to the Treasury. The Anglo-Indian community is an entrepreneurial one. Research last year showed that Indian diaspora-owned companies have a combined revenue of over £35 billion and employ over 174,000 people. British Indians have reached the top of business, politics, the professions, science, the arts and other areas of public life. Indian culture has mainstream appeal whether it’s food and the ubiquitous curry house or film through Bollywood classics.

Fourth, the C of Commonwealth is an important glue in the relationship. India, of course, is the giant of the association. It joined in 1949 as a founding member when Nehru explained: “We join the Commonwealth because we think it is beneficial to us and to certain causes in the world that we wish to advance …….it is better to keep a co-operative association going which may do good in this world rather than break it.” Having hosted the last Commonwealth Summit, the UK is the Chair- in-Office and with India, they are two pivotal forces in working together to maximise its effectiveness.

The final C is climate change. Later on this year, in November the UK will host the global climate change talks, COP-26. India is a key country and is one of the countries which could be most affected by global warming. There is scope to collaborate on shared solutions, which is already happening on issues such as scaling up the electric mobility markets.

Whilst Boris Johnson’s recent planned visits to India have been cancelled twice, there is so much potential in the UK and India relationship. Together our two countries can work together on shared challenges and mutually beneficial trade. In cricket, India has just won an exciting Test Series at home, and (Covid-permitting) will hopefully play on English soil this summer. Whilst it’s winner-takes-all on the cricket field, we can plot a better future together by focusing on the 5 C’s, and enable the bilateral relationship to go from strength to strength.”

Export Deal Secured with India

10 Downing Street

Morningside Pharmaceuticals is delighted to be involved in one of 20 export deals signed, as part of the newly agreed Enhanced Trade Partnership between the UK and India.

The deal is connected to researching, developing and licencing new pharma products and is among an extra £1 billion of agreed additional UK-India trade and investment, which looks set to create 6,500 jobs.

In announcing the deal, The UK Prime Minister, Boris Johnson, said: “Like every aspect of the UK-India relationship, the economic links between our countries make our people stronger and safer. Each and every one of the more than 6,500 jobs we have announced today will help families and communities build back from coronavirus and boost the British and Indian economies.

“In the decade ahead, with the help of the new Partnership signed today and a comprehensive Free Trade Agreement, we will double the value of our trading partnership with India and take the relationship between our two countries to new highs.”

The package contains over £533m of new Indian investment into the UK, which is expected to create more than 6,000 jobs in vital and growing sectors such as health and technology, and £200m of these deals will support low carbon growth. The package includes a £240 million investment by the Serum Institute of India in the UK into their vaccine business and a new sales office which will create a large number of jobs.

The 20 British businesses alongside Morningside have secured new export deals with India worth more than £446 million, which will drive UK growth and create more than 400 British jobs.

Dr Nik Kotecha OBE, Chairman of Morningside Pharmaceuticals, said: “We are immensely proud to be included alongside other UK exporters in the new trading arrangements, which have been announced with India. This enhanced trading relationship is a great step forward towards a future free trade agreement, which would bring significant opportunities for exporters, as well as investment, into the UK and the Midlands.

“The Morningside companies have invested in India for many years, particularly in Research & Development and clinical trials, as well as through our manufacturing investments into developing new formulations of generic medicines for our UK and international markets.

“We are proud that much of the innovation takes place here in Leicestershire and is then ‘Technology Transferred’ to Indian partners to help bring new formulations of generic and branded medicines to the UK and global markets quicker.

“In this way, we are able to identify niche difficult to develop and manufacture molecules in a wide range of therapeutic areas. This makes our patients’ experience of taking their medicines easier, as well as delivering cost savings to the NHS and our International Aid partners.”

The announcement coincides with a plan from both sides to agree an Enhanced Trade Partnership, which it is hoped will unlock new opportunities for British businesses exporting to India and Indian businesses investing in the UK.

It is expected that the closer trading relationship will lead to the doubling of the value of UK-India trade by 2030, as well as signal of negotiations towards a comprehensive Free Trade Agreement.

Read more here on the UK Government’s .Gov website.

Our LOROS Rocket Takes Flight

LOROS Rocket Round Leicester

T-minus 3 months and counting until the LOROS Hospice Rocket Round Leicester giant rocket art trail lands on 19th July, before blasting off on Sunday, 26th September.

Everyone at Morningside Pharmaceuticals Ltd is incredibly excited about our sponsored rocket entitled ‘Hopes Dream and Wishes’ which will be among 40 giant ‘out of this world’ instillations scattered around Leicester city centre.

We can’t reveal the full design yet but here’s a sneak peak of the very talented Lynne Hollingsworth putting the finishing touches to it. As you can see we’re nearing Lift Off!

Visitors to the art trail will steer a voyage of discovery through the city’s streets and open spaces and help even life-long Leicester dwellers discover something new about where they live. Each Rocket will be designed by a professional artist and sponsored by local businesses. With a likely footfall of around 300,000 people, bringing in an expected £6 million to the local economy, Rocket Round Leicester will form a pivotal part of the city’s post-pandemic economic recovery, as well as a brilliant day out for everyone.

After the trail ends there will be the chance to say a final ‘goodbye’ at a Farewell Event, before each Rocket is auctioned to raise funds for LOROS Hospice to enable them to continue to care for over 2,500 terminally ill local people.

Dr Nik Makes the Power List 2021

Medicine Maker Power List 2021

We’re delighted to reveal that our Chairman, Dr Nik Kotecha OBE, has been named as one of 60 international leaders and innovators across the pharma industry to feature in the Power List 2021.

The list, compiled by The Medicine Maker magazine, celebrates the success stories of the best and brightest individuals in three distinct categories including Small Molecules, Biopharmaceuticals and Advanced Medicine. Dr Kotecha is honoured to be amongst the 20 leaders and innovators in the Small Molecules category.

To View the full Power List 2021 visit here.   

Readers of The Medicine Maker were invited to submit nominations for the Power List and the final list was compiled with the help of an anonymous judging panel.

Setting the scene for the 2021 Power List, the magazine said that the pharma industry has faced enormous challenges over the last 12 months as it strives to develop new vaccines and treatments to help the world find a way out of the pandemic.

Everyday life has changed drastically, but scientists and leaders in the pharma industry have demonstrated enormous dedication and resources to the fight – despite the uncertainty.

Now in 2021, the pandemic is not over – and won’t be for some time – but there are reasons to feel optimistic. Effective vaccines have been approved by many regulators for emergency use, existing drugs are being repurposed to help patients with severe COVID-19, and new drug development is vibrant. Small molecules, biopharmaceuticals, and even cell therapies are all being explored as potential medicines to combat COVID-19. The industry has genuinely outdone itself. And, alongside interventions against COVID-19, work continues tirelessly to address other crucial therapeutic areas.

Editor of The Medicine Maker, Stephanie Sutton, explains, “It has been remarkable to see the progress the pharma industry has made over the last 12 months. Companies have stepped up to the challenge and delivered; new vaccines typically take around a decade to reach the market, but COVID-19 vaccines have gone from discovery to real-world use in less than a year. Many individuals on our Power List have contributed to the fight against the pandemic, but everyone on the list – whether they are involved in COVID-19 vaccine and drug development or not – is playing a key role in moving us all towards a healthier world, from developing ground-breaking new treatments to devising new manufacturing strategies”.

Dr Kotecha added: “It’s a real honour to be included in the Power List 2021 , which has this year recognised 60 international leaders and innovators in the pharma industry.

“I’m truly humbled to feature alongside the best and brightest individuals working in Small Molecules, Biopharmaceuticals and Advanced Medicine.”

Apprenticeship Talk for Leicestershire Cares

Leicestershire Cares

Well done to two of our former apprentices who have taken part in a virtual careers advice session with students from Leicestershire’s secondary schools.

Executive Assistant Ria Wicks and HR Assistant Chloe Newton-Pell volunteered to share their journeys into the world of work at Morningside on the Leicestershire Cares webinar.

During the session both colleagues, who worked as well as gained a qualification from Loughborough College during their apprenticeships, spoke about their life experiences of building a career with Morningside.

They also talked about how their apprenticeships have helped them develop into their current roles, what they entail and their top tips for current school and college leavers who are thinking about their futures.

The live event, which was also filmed and will be shared with every secondary school in Leicestershire, was organised by Leicestershire Cares, which specialises in working with schools and young people to support employability.

To find out more about Leicestershire Cares visit here: https://www.leicestershirecares.co.uk/